Kaur D - Search Results

1

Does cellular iron dysregulation play a causative role in Parkinson's disease?

Kaur D, Andersen J. Kaur D, et al. Ageing Res Rev. 2004 Jul;3(3):327-43. doi: 10.1016/j.arr.2004.01.003. Ageing Res Rev. 2004. PMID: 15231240 Review.

2

The hunt for a cure for Parkinson's disease.

Andersen JK, Kumar J, Srinivas B, Kaur D, Hsu M, Rajagopalan S. Andersen JK, et al. Among authors: kaur d. Sci Aging Knowledge Environ. 2001 Oct 3;2001(1):re1. doi: 10.1126/sageke.2001.1.re1. Sci Aging Knowledge Environ. 2001. PMID: 14602952 Review.

3

Glutathione, iron and Parkinson's disease.

Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK. Bharath S, et al. Among authors: kaur d. Biochem Pharmacol. 2002 Sep;64(5-6):1037-48. doi: 10.1016/s0006-2952(02)01174-7. Biochem Pharmacol. 2002. PMID: 12213603 Review.

4

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK. Kaur D, et al. Neuron. 2003 Mar 27;37(6):899-909. doi: 10.1016/s0896-6273(03)00126-0. Neuron. 2003. PMID: 12670420 Free article.

5

Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?

Kaur D, Andersen JK. Kaur D, et al. Aging Cell. 2002 Oct;1(1):17-21. doi: 10.1046/j.1474-9728.2002.00001.x. Aging Cell. 2002. PMID: 12882349 Free article. Review.

6

Iron dysregulation and neurodegeneration: the molecular connection.

Lee DW, Andersen JK, Kaur D. Lee DW, et al. Among authors: kaur d. Mol Interv. 2006 Apr;6(2):89-97. doi: 10.1124/mi.6.2.6. Mol Interv. 2006. PMID: 16565471

7

Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age.

Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, Andersen JK. Kaur D, et al. Neurobiol Aging. 2007 Jun;28(6):907-13. doi: 10.1016/j.neurobiolaging.2006.04.003. Epub 2006 Jun 12. Neurobiol Aging. 2007. PMID: 16765489

8

Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease.

Kaur D, Lee D, Ragapolan S, Andersen JK. Kaur D, et al. Free Radic Biol Med. 2009 Mar 1;46(5):593-8. doi: 10.1016/j.freeradbiomed.2008.11.012. Epub 2008 Dec 3. Free Radic Biol Med. 2009. PMID: 19118623 Free PMC article.

9

A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease.

Lee DW, Kaur D, Chinta SJ, Rajagopalan S, Andersen JK. Lee DW, et al. Among authors: kaur d. Antioxid Redox Signal. 2009 Sep;11(9):2083-94. doi: 10.1089/ars.2009.2489. Antioxid Redox Signal. 2009. PMID: 19290777 Free PMC article.

10

Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.

Kaur D, Rajagopalan S, Andersen JK. Kaur D, et al. Brain Res. 2009 Nov 10;1297:17-22. doi: 10.1016/j.brainres.2009.08.043. Epub 2009 Aug 21. Brain Res. 2009. PMID: 19699718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page